You are here

Clinical Trials: Lung Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Monday, May 25, 2020 - 12:00
Conditions:   Acute Respiratory Distress Syndrome;   Covid19
Intervention:   Biological: Mesenchymal Stromal Cells
Sponsors:   Ottawa Hospital Research Institute;   Stem Cell Network
Not yet recruiting
Posted: Friday, May 22, 2020 - 12:00
Condition:   COVID-19 Pneumonia
Interventions:   Biological: ACT-20-MSC;   Biological: ACT-20-CM;   Biological: Placebo
Sponsor:   Aspire Health Science
Not yet recruiting
Posted: Friday, May 15, 2020 - 12:00
Conditions:   COVID-19;   SARS-CoV 2;   Adult Respiratory Distress Syndrome
Interventions:   Drug: XCEL-UMC-BETA;   Other: Placebo
Sponsor:   Banc de Sang i Teixits
Recruiting
Posted: Tuesday, May 12, 2020 - 12:00
Conditions:   Corona Virus Infection;   COVID-19;   SARS;   Acute Respiratory Distress Syndrome
Interventions:   Biological: OrganicellTM Flow;   Other: Placebo
Sponsor:   Organicell Regenerative Medicine
Not yet recruiting
Posted: Monday, May 11, 2020 - 12:00
Conditions:   COVID;   Covid-19;   Coronavirus;   Pneumonia;   Pneumonia, Viral;   Pneumonia, Interstitial;   Sars-CoV2
Interventions:   Biological: Allogenic pooled olfactory mucosa-derived mesenchymal stem cells;   Other: Standard treatment according to the Clinical protocols
Sponsors:   Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus;   Belarusian State Medical University
Not yet recruiting
Posted: Tuesday, April 28, 2020 - 12:00
Condition:   Covid-19
Interventions:   Biological: Cell therapy protocol 1;   Biological: Cell therapy protocol 2
Sponsors:   Royan Institute;   Tehran University of Medical Sciences;   Shahid Beheshti University of Medical Sciences
Recruiting
Posted: Tuesday, April 28, 2020 - 12:00
Conditions:   Coronavirus;   Coronavirus Infection;   Severe Acute Respiratory Syndrome Coronavirus 2;   Pneumonia;   Pneumonia, Viral;   Lung Diseases;   Respiratory Tract Disease;   Respiratory Tract Infections;   Coronaviridae Infections;   Nidovirales Infections;   RNA Virus Infections;   Virus Disease;   Immunologic Disease;   ARDS;   Immunologic Factors;   Physiological Effects of Drugs;   Antiviral Agents;   Anti-infective Agents;   Analgesics;   Antimetabolites, Antineoplastic
Intervention:   Biological: CYNK-001
Sponsors:   Celularity Incorporated;   IDRI;   Lung Biotechnology PBC
Not yet recruiting
Posted: Tuesday, April 28, 2020 - 12:00
Condition:   Sars-CoV2
Intervention:   Drug: ALLOGENEIC AND EXPANDED ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS
Sponsor:   Andalusian Network for Design and Translation of Advanced Therapies
Not yet recruiting
Posted: Friday, April 24, 2020 - 12:00
Condition:   COVID-19 Pneumonia
Interventions:   Biological: Mesenchymal Stromal Cells;   Other: Placebo
Sponsors:   Red de Terapia Celular;   Citospin;   University of Valladolid;   Castilla-León Health Service;   Hospital del Río Hortega;   Instituto de Salud Carlos III
Not yet recruiting
Posted: Tuesday, April 21, 2020 - 12:00
Conditions:   Corona Virus Infection;   ARDS;   ARDS, Human;   Acute Respiratory Distress Syndrome
Interventions:   Biological: Umbilical Cord Mesenchymal Stem Cells;   Other: Standard of Care
Sponsor:   Camillo Ricordi
Recruiting

Pages